
Italy · research
Repron provides treatments for solid tumour cases where radical excision is not possible and metastasis or recurrence is extremely likely.
PrivateFor profit
Set against 32 research companies in Italy. The ring marks the typical peer.
Across all 5.9M companies: larger than 0% of those with a size listed; older than 0% of those with a founding year.
BiotechnologyHealth Care
What the source datasets report. We have not watched these rounds ourselves.
$2.1M
raised in total, currency not stated across 1 round
Last raised Jun 2023, 3 years ago
Everything the source datasets list about Repron Therapeutics, field by field. Contact details are held but never shown.
The company6 fields
Where3 fields
Size and reach1 field
Funding, as listed7 fields
About this record2 fields
32 research companies in Italy, filtered by size, age and reach, ready to export with emails on Pro.